In recent years, thanks to investments in the pharmaceutical sector and the free trade agreement with some countries, exports of pharmaceutical products has increased in Turkey, which usually is an importer. According to statistical data from TUIK, Turkish pharmaceutical exports increased by 25% in 5 years, reaching 827 million dollars. In the same period, however, import has increased by only 5.5%. The trade deficit equals to 57 million dollars. South Korea (millions of dollars over the period of 2012-2016), Switzerland (59.7 million dollars) and Iraq (48.6 million dollars) are the first countries importing pharmaceutical products from Turkey. 

The export of Abdi Ibrahim, one of the largest Turkish pharmaceutical companies, increased by 92% (from USD 78.3 million in 2015 to 150.4 million dollars in 2016). the company’s export target is 256 million dollars in 2017. Mainly parkinson, asthma, schizophrenia, iron deficiency and sore throat products are exported.


Source: medNews